Business
EU Eyes Canada as First Potential Associate Member
European Commission President Ursula von der Leyen proposes expanding ties with Canada to an associate membership status, marking a potential shift in EU-Canada relations.
Baltic Classifieds Group appoints Sean Glithero as independent director
Sean Glithero, a qualified Chartered Accountant with extensive finance experience, joins the board of Baltic Classifieds Group PLC as an independent non-executive director, set to chair the Audit Committee from January 2027.
SWISSto12 Partners with Mitsubishi Electric on Satellite Tech
Swiss satellite maker SWISSto12 signed an MoU with Mitsubishi Electric to pursue joint opportunities in Japan and Asia Pacific, while also landing a contract for phased array antennas for Japan's secure communications program.
FDA Accepts Takeda’s zasocitinib Application for Plaque Psoriasis
Takeda’s oral TK2 inhibitor for moderate-to-severe plaque psoriasis enters FDA review, with a target action date set for Q1 2027 under PDUFA.
Sun Hung Kai Properties Posts Higher H2 Profit, Raises Dividend
Hong Kong developer reports underlying profit of HKD 22.9 billion for FY2026, up 4.6%, as property development gains and healthier balance sheet offset cautious 2027 sales guidance.
Tyson Foods trims beef, chicken guidance and highlights brand growth at Barclays conference
At a Barclays consumer conference, Tyson Foods cut its beef, chicken and pork forecasts, announced an incoming CEO and outlined a push to develop several emerging brands.
Palomar Sees Growth Broaden Across Lines as Earnings Streak Hits 15
Palomar Holdings reported 27% first-half earnings growth and raised guidance for a third time in 2026, citing expanding crop, surety and reinsurance businesses at the KBW Insurance Conference.
Charter Raises Cox Synergy Target to Over $1 Billion, Trims Leverage Goal
CFO Jessica Fischer said Charter’s combined footprint will exceed 70 million passings post-integration, with nearly half the Cox synergies expected quickly.
C2N Diagnostics partners with Cambridge Cognition to deliver integrated Alzheimer’s diagnostics in the UK
The collaboration combines C2N's PrecivityAD2 blood test with Cambridge Cognition's CANTAB Pathway cognitive assessment, using The Alzheimer’s Trust's phlebotomy and MRI network to address the UK's dementia diagnosis gap.
Digital 9 Infrastructure switches auditors ahead of wind-down
Jersey-based infrastructure trust appointed Johnston Carmichael LLP as external auditor following PwC’s departure in September 2024, with shareholder approval required at the 2027 AGM.
Coiled Therapeutics completes Phase I trial enrollment for AO-252 lipid formulation
Six patients enrolled in dose cohorts testing a new lipid-based softgel formulation of the TACC3 inhibitor AO-252, with initial safety and pharmacokinetic data expected by year-end.
New Jersey Resources raises quarterly dividend to $0.50 per share
The utility company said the increase, to $2.00 on an annualized basis, marks its 31st consecutive year of dividend hikes, reflecting board confidence in its financial strength.
Gaming & Leisure Properties Hits 52-Week Low at $41.16
GLPI stock falls to its lowest level in a year despite reporting strong Q2 2026 results that beat on revenue and earnings.
TotalEnergies to Repay €1.5B in Subordinated Notes by Mid-October
The oil and gas giant plans to redeem €1.5 billion of deeply subordinated notes under its €35 billion Euro Medium Term Note Programme, with redemption scheduled for October 6, 2026.
German Auto Workers Mobilize for Nationwide Union Protests
IG Metall calls for more than 280 actions across Germany as automakers face overcapacity, job cuts and rising Chinese competition.
mAbxience and Sandoz Team Up on Emicizumab Biosimilar
Fresenius-owned mAbxience and Sandoz signed a licensing, development, manufacturing and commercialization agreement for an emicizumab biosimilar referencing Hemlibra, with an estimated global reference market of around $5.7 billion.
Anthropic's $517bn compute spend and $2tn IPO target contrast with CEO's call to slow AI
Anthropic has committed $517bn to AI compute through August 2026 and aims for a $2tn Nasdaq IPO, even as its CEO urges the industry to temper development speed.
Jazz Pharmaceuticals Raises ZYHERA Sales Guidance Amid Rare-Disease Expansion
Revenue hits $1.2 billion in Q2 2026 as Jazz Pharmaceuticals accelerates pipeline growth, citing strong performance across key brands and strategic acquisitions.
iA Financial Group targets 17%+ ROE and growth at Scotiabank summit
CEO Denis Ricard said iA Financial aims for a 17%‑plus return on equity, modest buybacks and expansion of its U.S. insurance business while investing heavily in AI tools.
Iovance Raises Outlook on AMTAGVI Sales Momentum at Wells Fargo Conference
Cash-rich biotech sees Q2 AMTAGVI sales surge 52%, gross margins jump; guides to ~70% long-term gross margin with runway into late 2028.
Groupe Dynamite beats Q2 EPS forecast and lifts FY guidance
Adjusted diluted EPS rose to C$0.96, topping the C$0.41 outlook, while revenue jumped 29.8% YoY to C$423.6 million.
Oregon Bancorp Declares $0.20 Quarterly Dividend
The Willamette Valley Bank parent sets a payable date of Oct. 15, 2026, reinforcing its commitment to shareholder returns.
Zurich Appoints Alex Wells as Head of US Operations
Zurich Insurance names internal candidate Alex Wells to lead its US business, replacing Sierra Signorelli who departs after nine years with the firm.
Brady Tops Q4 Estimates but Shares Drop as Guidance Weighs on Investors
Brady Corp reported Q4 adjusted EPS of $1.48 on $436.9M revenue, beating estimates, but shares fell premarket as the company issued modest full-year guidance and highlighted integration costs from its Honeywell acquisition.
Protagonist Therapeutics reports $850M cash, $300M buyback, launches oral IL-23 drug
The biotech firm ended Q2 with $850 million in cash, announced a $300 million share repurchase and introduced icotrokinra, an oral IL‑23 blocker for inflammatory diseases.